Remember folks, this price action has absolutely nothing to do with the fundamental value of the company. No one here is buying based on intimate knowledge of the phase 3 BETonMACE trial. That's to say, this recent uptick in the shareprice in no way validates the company's drug. If it makes you feel better any downside move also does not mean the drug is useless. In short, nothing matters but the actual trial results.